MedPath

Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale

Conditions
Foramen Ovale, Patent
Registration Number
NCT04987008
Lead Sponsor
University Hospital, Brest
Brief Summary

stroke's risk is increased in patients with pulmonary embolism and PFO compared to patients without PFO. Does this increased risk persist years after pulmonary embolism ?

Detailed Description

324 patients included in EPIC-FOP study (2009 to 2015) were followed annually to collect data about the recurrence of VTE, cardiovascular events and treatments.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
53
Inclusion Criteria
  • patients included in EPIC-FOP study
Exclusion Criteria
  • refusal to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
strokepulmonary embolism (2009 to 2015) to 2021

documented stroke

Secondary Outcome Measures
NameTimeMethod
VTEpulmonary embolism (2009 to 2015) to 2021

recurrent VTE

TIA or strokepulmonary embolism (2009 to 2015) to 2021

documented TIA or stroke

deathpulmonary embolism (2009 to 2015) to 2021

all deaths and cardiovascular deaths

bleedingpulmonary embolism (2009 to 2015) to 2021

Major and clinically pertinent bleeding (ISTH classification)

Trial Locations

Locations (3)

HIA

🇫🇷

Brest, France

CHRU de Brest

🇫🇷

Brest, France

CHIC de Quimper

🇫🇷

Quimper, France

© Copyright 2025. All Rights Reserved by MedPath